Diabetologia 61 , 21082117 (2018)
One mechanism detail worth knowing: repeated high doses can blunt the response over time (desensitization), which is part of why dosing near the saturation point, not above it, is the common approach
Structurally, it shares 94% sequence homology with human GLP-1 but includes two critical modifications: the substitution of amino acids to prevent enzymatic degradation by Dipeptidyl Peptidase-4 (DPP-4), and the addition of a C-18 fatty di-acid side chain
If youre ready to take the next step toward achieving your health goals, book an appointment with us today
Liraglutide was the GLP-1RA used in most animal studies (Table 1)
A confident, qualified provider will answer these questions readily